What To Expect in Markets This Week: AMD, Palantir, Pharmaceutical and Tech Earnings; Private-Sector Employment Report

This week's market attention is primarily on earnings reports, with tech firms, particularly AI-chip makers like Advanced Micro Devices, Qualcomm, and Arm Holdings, and software provider Palantir, expected to be in focus. Pharmaceutical companies including Novo Nordisk, Amgen, and Pfizer will also report amidst pressure on drug pricing, alongside gig economy leaders such as Uber and DoorDash. Concurrently, the U.S. government shutdown is delaying official employment data, though private-sector ADP employment and ISM surveys will offer economic insights, while investors also anticipate remarks from Federal Reserve officials following the central bank's recent interest rate cut.

Analysis

This week's earnings calendar is heavily weighted towards technology firms, with significant investor focus on artificial intelligence demand. Chipmakers Advanced Micro Devices (AMD), Qualcomm (QCOM), and Arm Holdings (ARM) are reporting, with AMD's recent Oracle AI chip deal and Qualcomm's new data center AI chips highlighting sector growth. Palantir (PLTR) stands out, with its shares having more than doubled this year driven by strong demand for its AI platforms, reflecting robust market sentiment (PLTR sentiment: 0.8).

Pharmaceutical earnings, including Novo Nordisk (NVO), Amgen (AMGN), and Pfizer (PFE), are under scrutiny amidst ongoing pressure from the Trump administration to lower drug prices. Novo Nordisk, maker of Ozempic, faces specific criticism over its pricing, with the President suggesting a $150 monthly cost versus the current $1,000+. This regulatory overhang (NVO sentiment: -0.6, AMGN/PFE/AZN sentiment: -0.3) is prompting firms to negotiate price reductions in response to tariff threats.

The U.S. government shutdown, now in its second month, continues to delay critical official economic data, including the monthly employment report. Investors will instead rely on the private-sector ADP employment report and ISM manufacturing and services surveys for labor market and economic insights. This occurs as the Federal Reserve recently enacted its second interest rate cut this year, with remarks from various Fed presidents anticipated to provide further monetary policy guidance.

Key Decisions for Investors

• Monitor AI-centric tech earnings closely, evaluating forward guidance on AI-related revenue and partnerships, especially for companies like Palantir and the chipmakers.
• Scrutinize pharmaceutical earnings reports for commentary on drug pricing strategies and potential impacts from regulatory pressure, particularly for firms facing direct government criticism like Novo Nordisk.
• Prioritize alternative economic indicators such as the ADP employment report and ISM surveys for timely insights into labor market health and broader economic activity, given the delays in official government data.
• Analyze statements from Federal Reserve officials for indications on future monetary policy direction following the recent interest rate cut, which could influence market liquidity and asset valuations.